Upper urinary tract surgery and radical prostatectomy with Senhance ® robotic system: Single center experience-First 100 cases

Int J Med Robot. 2021 Aug;17(4):e2269. doi: 10.1002/rcs.2269. Epub 2021 May 2.


Background: The Senhance® robotic surgery system is a novel robotic platform used in several European and World centres. We present our experience in urologic surgery using this platform.

Patients and methods: From May 2019 to December 2020, we performed 30 operations of upper urinary tract (UUT) and 70 extraperitoneal radical robotic prostatectomies (RRP). Relevant data were prospectively collected for key outcomes.

Results: The median age for UUT was 51, and for RRP 65 years. The average estimated blood loss for UUT was 30, and for RRP 200 ml. The average operating time for UUT was 160, and for RRP 200 min. In-hospital stay for UUT was on average 4, and for RRP 5 days. In UUT group, one patient had Clavien-Dindo complication grade II and one had IIIb. In RRP, three patients had grade I complications and three patients had grade II complications. Catheter was removed on average 8 days after RRP.

Conclusion: The Senhance® robotic system is a safe and feasible approach to urological surge.

Keywords: Senhance®; adrenalectomy; minimally invasive surgery; nephrectomy; prostate cancer; pyeloplasty; radical prostatectomy; robotics.

MeSH terms

  • Aged
  • Humans
  • Male
  • Prostatectomy
  • Prostatic Neoplasms* / surgery
  • Robotic Surgical Procedures*
  • Robotics*
  • Treatment Outcome
  • Urinary Tract*